Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg Extended Release Tablets USP Allergy & Congestion, 20 Tablets, Distributed by: Dr. Reddy's Laboratories, Inc. Princeton, NJ 08540, NDC 43598-823-14.
Published December 15, 2021 · Recall initiated: November 12, 2021
Summary
FDA records drug Class III recall D-0269-2022, published December 15, 2021 and initiated November 12, 2021. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 5016 cartons; Lot: Lot #: AC2103329F, Exp 1/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications
What to do
Letter
Get an email if FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- USA Nationwide.
- Lot
- Lot #: AC2103329F, Exp 1/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAWal-Fex D, Fexofenadine HCl 60mg/Antihistamine & Pseudoephedrine HCl 120mg/Nasal Decongestant, ExtendedJanuary 26, 2022
- FDAKroger, Allergy Relief-D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine HCl 120mg/Nasal Decongestant,January 26, 2022
- FDAFexofenadine HCl, 60 mg & Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy and Congestion, 30December 15, 2021
- FDAAllergy & Congestion Relief Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg ExtendedDecember 15, 2021
- FDAAntihistamine & Nasal Decongestant, Fexofenadine HCl 60 mg and Pseudoephedrine HCl 120 mg, Extended ReleaseDecember 15, 2021
- FDAAllergy & Congestion Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg Extended-Release Tablets, USP, 20December 15, 2021
Questions about this recall
Was Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg Extended Release Tablets USP Allergy & Congestion, 20 Tablets, Distributed by: Dr. Reddy's Laboratories, Inc. Princeton, NJ 08540, NDC 43598-823-14. recalled?
Yes. FDA published recall D-0269-2022 on December 15, 2021. Reported hazard: Failed dissolution specifications
What should I do if I have this product?
Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI.